Patient Access as the Gateway to Health Care

We believe that access to care is a fundamental right. Therefore, we are committed to facilitating Patient Access, which is the ability of patients to reach and obtain the most appropriate and personalized care and assistance possible.

Market Access and Patient Access: A Holistic Approach

We work on access in its dual meaning.

We specialize in Market Access, which is the set of activities through which a company introduces a given drug or medical device to the market, making it available to people with diseases.

Introducing a product to the market, however, is not enough. It is necessary to ensure that the individual also has smooth access to the drug or medical device.

We are, therefore, also passionate about Patient Access, understanding the needs and challenges patients face in their care journey and working to ensure that people can promptly reach and obtain necessary and appropriate diagnosis, treatment, and care.

The value of our Access

The differentiating value of our access projects is the inclusion of the voice of people with diseases, in a structured and evidence-based way. Understanding how a disease or therapy is experienced by the patient, in terms of physical, psychological, and social functioning, is critical to creating successful strategies.

Our structured and scientifically validated quantitative and qualitative surveys enable us to:

Identify patients’ unmet needs.
Understanding barriers to accessing care.
Develop targeted and customized access strategies.
Measuring the impact of our strategies on patients’ lives.

Our market access and patient access services

ASSESSMENT AND VALUE HISTORY

We analyze product and context characteristics for a better pharmaceutical needs assessment and to strengthen the value proposition.

Find out more

OUTSOURCING AND MARKET ACCESS SKILLS

We provide companies with staffing services and training in market access.

Find out more

VALUE COMMUNICATION

We develop strategies to communicate the value of the product and affirm it in the minds of stakeholders.

Find out more

Our Access projects

Supporting Corporate Market Access

A large pharmaceutical group found it necessary to adapt its internal organization to market fragmentation. Therefore, it asked for our support to speed up the access process of two drugs in the company’s formularies, obtain a detailed description of the access pathways and the necessary documentation in 66 centers in Italy.

T-ema

A pathway to compare and share skills and solutions used in the daily practice of the Hospital Pharmacist in reference to rare diseases. A series of Advisory Boards identified clinical practice obstacles, gathering solutions and best practices.

Discover more